Boulder-based Inscripta is a gene editing technology company. Founded in 2015 by Andrew Garst, Ryan T Gill, and Tanya Lipscomb, Inscripta, Inc is backed by investors that include Foresite Capital, Merieux Developpement, NanoDimension, Paladin Capital Group, and Venrock.